TheEdgeResearch
Home / Stocks / RWBYF

Red White & Bloom Brands Inc. (RWBYF)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.03 ▲ +1.82%
Market Cap
$13.7M
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
0.55
52-Wk Range
1.0E-4-0.1446
CEO
Brad Rogers
Country
CA
Currency
USD

Red White & Bloom Brands Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Vancouver, BC, CA. The stock last traded at $0.03, up 1.82% on the session, giving a market capitalisation of $13.7M. On trailing twelve-month figures it carries a trailing P/E of -0.14, a net margin of -157.2%. Its beta of 0.55 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-0.14
Price / Sales
0.22
Price / Book
-0.14
EV / EBITDA
-2.58
Gross margin
33.4%
Operating margin
-9.4%
Net margin
-157.2%
Return on equity
—
Debt / equity
-1.91
Current ratio
0.25
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
—
IPO date
2021-01-08
Headquarters
Vancouver, BC, CA
About Red White & Bloom Brands Inc.

Red White & Bloom Brands Inc. is actively involved in the cultivation and sale of cannabis goods. It maintains a significant operational footprint primarily across Michigan, California, Florida, and Oklahoma. The enterprise is based in Vancouver, Canada.

Comparable companies

Red White & Bloom Brands Inc. is most often compared with the following Healthcare names:

BFFTFCNPOFHMPSFMGCLFMRVFFNXTTFPKANFRAMMFRXMDTMDIF
More research on RWBYF
RWBYF technical analysis RWBYF TheEdge Score Compare against peers
Open full interactive analysis & DCF →